COVID-19: Vaccines and Therapeutics
The U.S. District Court for the Eastern District of Missouri today granted a preliminary injunction preventing the Centers for Medicare & Medicaid Services from enforcing its vaccine mandate rule in Alaska, Arkansas, Iowa, Kansas, Missouri, Nebraska, New Hampshire, North Dakota, South Dakota…
A two-dose series of the Pfizer-BioNTech COVID-19 vaccine was 100% effective against COVID-19 in 12-14 year olds more than four months after the second dose in the companies’ phase 3 clinical trial, Pfizer and BioNTech announced.
Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., expanded eligibility for COVID-19 booster shots to include all adults aged 18 and older who received a second dose of the Pfizer or Moderna vaccine at least six months ago, as recommended by the agency’s Advisory Committee…
The Food and Drug Administration authorized a single booster dose of the Pfizer or Moderna COVID-19 vaccine for all individuals aged 18 or older at least six months after receiving the initial two-dose series or two months after receiving the single-dose Johnson & Johnson vaccine.
One chapter in a UK HealthCare video series focuses on its NICU, PICU and labor and delivery teams, who are caring for the “sickest patients this hospital is seeing at times” and urging pregnant women to get vaccinated.
GCH is using logic and convenience to break down barriers and get shots into the arms of kids and their caregivers.
The federal government will purchase 10 million treatment courses of the COVID-19 oral antiviral Paxlovid from Pfizer if the Food and Drug Administration approves or authorizes the drug for emergency use, the administration announced.
The Occupational Safety and Health Administration has suspended activities related to implementation and enforcement of its Emergency Temporary Standard on COVID-19 vaccination and testing pending future developments in litigation, the agency announced on its website.
The Occupational Safety and Health Administration has suspended activities related to implementation and enforcement of its Emergency Temporary Standard on COVID-19 vaccination and testing pending future developments in litigation, the agency announced on its website.
Texas filed a federal lawsuit challenging the Centers for Medicare & Medicaid Services’ interim final rule requiring COVID-19 vaccinations for workers in most health care settings that participate in the Medicare and Medicaid programs, including hospitals and health systems.